-The Hindu As the borewells go deeper in Maharashtra, there have been worrying instances of ‘paleo-historic storages' being breached "Only two of them work," says Badri Kharat of his borewells in Roshangaon. That's hard - when you've sunk 36 of them spending millions of rupees, as he has. Kharat, a big landowner and local political personage, has been generous to his neighbours in this village of Jalna district. He pipes in drinking...
More »SEARCH RESULT
Total Matching Records found : 2155
Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »Gujarat Information Commission suggests RTI action plan
-The Times of India AHMEDABAD: Many public authorities in the state neglect record keeping and maintenance and there was a need to change the mindset of the establishment at the local self government, theGujarat Information Commission (GIC) has observed. The GIC, in its annual report for the year 2011-12, has stated every public authority should maintain all records in proper format and even suggested that computerization of the data should be done...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »Why Novartis case will help innovation-Achal Prabhala and Sudhir Krishnaswamy
-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...
More »
